Results 121 to 130 of about 15,139,370 (299)
Objective The aim of this study was to characterize the prevalence and correlates of dietary supplement use, identify commonly used supplements, and evaluate potential supplement–medication interactions among adults with systemic lupus erythematosus (SLE).
Sarah L. Patterson +7 more
wiley +1 more source
Small‐Bowel Capsule Endoscopy in Immune‐Mediated Enterocolitis: A Case Series of Four Patients
Immune checkpoint inhibitors (ICIs) have emerged as a cornerstone of cancer immunotherapy but are associated with immune‐mediated adverse events (imAEs), including gastrointestinal toxicities.
Masayuki Orikasa +11 more
doaj +1 more source
Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
The increased use of immune checkpoint inhibitors (ICIs) across cancer programs has created the need for standardized monitoring and management of immune-related adverse events (irAEs).
Parneet K. Cheema +17 more
doaj +1 more source
Objective The objective of this scoping review was to synthesize evidence on the proportion of individuals living with Sjögren's disease who experience central nervous system (CNS) manifestations. Methods We searched MEDLINE (via PubMed) and Embase from 1980 through January 29, 2026, and the ECRI Guidelines Trust from 2020 through January 29, 2026 ...
Arun Varadhachary +21 more
wiley +1 more source
Background Immune checkpoint inhibitors (ICIs) have uncommon associations with cardiotoxicity, yet these cardiotoxic effects are associated with high mortality.
Akash Sharma +7 more
doaj +1 more source
Objective This study aimed to determine whether gout flare resolution is associated with physical activity and sleep. These findings were intended to inform the future development of a definition for flare resolution. Methods Data from 81 participants with gout who experienced at least one flare during a six‐month prospective observational study were ...
Sarah Stewart +12 more
wiley +1 more source
Immune-Related Dermatologic Reactions in Cancer Patients Undergoing Immunotherapy: A Case Series
Immune checkpoint inhibitors (ICIs) have transformed the treatment paradigm across various malignancies by reactivating T cell responses against tumor cells.
Raja Chhabra +5 more
doaj +1 more source
Clinical and translational attributes of immune-related adverse events
With immune checkpoint inhibitors (ICIs) becoming the mainstay of treatment for many cancers, managing their immune-related adverse events (irAEs) has become an important part of oncological care. This Review covers the clinical presentation of irAEs and crucial aspects of reversibility, fatality and long-term sequelae, with special attention to irAEs ...
Karijn P. M. Suijkerbuijk +3 more
openaire +3 more sources
Immune-Related Adverse Events of Immune Checkpoint Inhibitors
Immune-Related Adverse Events of Immune Checkpoint Inhibitors. Charoo Iyer, Chief Resident, Rochester General Hospital Internal Medicine Residency Program; Chengu Niu, Chief Resident, Rochester General Hospital Internal Medicine Residency Program; Ido ...
Patel, Mehul +3 more
core
Objectives We aimed to estimate whether adding oral glucocorticoids to ILD‐modifying therapy improves 12‐month lung outcomes in systemic sclerosis‐associated interstitial lung disease (SSc‐ILD). Methods We emulated a target trial using the EUSTAR database.
Zubeyir Salis +14 more
wiley +1 more source

